BLRX

BioLineRX
BLRX

29 hedge funds and large institutions have $1.49M invested in BioLineRX in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 5 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

30% less capital invested

Capital invested by funds: $2.12M → $1.49M (-$639K)

85% less call options, than puts

Call options by funds: $33K | Put options by funds: $223K

Holders
29
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$33K
Puts
$223K
Net Calls
Net Calls Change

Top Buyers

1
+$170K
2
+$83.9K
3
+$35.3K
4
Wells Fargo
Wells Fargo
California
+$26.3K
5
TSS
Two Sigma Securities
New York
+$19.3K

Top Sellers

1
-$207K
2
-$48K
3
-$38K
4
JP Morgan Chase
JP Morgan Chase
New York
-$36.1K
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$29.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$2K
27
$1.35K
28
$224
29
–
30
–
31
–
32
–
1
2